Latest News in the pharma Industry
Top Stories
Merck's omarigliptin achieved similar A1C reductions to Januvia in patients with type 2 diabetes inadequately controlled on Metformin monotherapy
17 Sep 2015
Omarigliptin was found to be non-inferior to Merck’s once-daily DPP-4 inhibitor, Januvia (sitagliptin), at reducing patients’ A1C levels from baseline, with similar A1C reductions achieved in both groups.
Read more
Using proteomics to understand how genetic mutations rewire cancer cells
17 Sep 2015
Scientific publications highlight studies using data from Thermo Scientific Orbitrap mass spectrometry and next-generation sequencing to discover how cancer attacks the protein networks controlling human cells
Read more
Sandoz inaugurates BioInject — a new biopharmaceutical manufacturing facility in Schaftenau, Austria
17 Sep 2015
BioInject is a state-of-the-art facility that will be used to manufacture pre-filled syringes and devices for both Sandoz’s biosimilars and Novartis Pharma’s novel biologics.
Read more
Technical knowledge alone is not enough for pharmaceutical professionals
16 Sep 2015
Pharmaceutical professionals must develop wider commercial and business skills if they want to continue to secure the top jobs, according to NonStop Recruitment.
Read more
Amgen to acquire privately-held Dezima Pharma
16 Sep 2015
Dezima's lead molecule is TA-8995, an oral, once-daily cholesteryl ester transfer protein (CETP) inhibitor.
Read more
BMS’s Opdivo (nivolumab) receives breakthrough therapy designation from FDA for advanced renal cell carcinoma
16 Sep 2015
This is the fourth Breakthrough Therapy Designation granted for Opdivo by the FDA
Read more
Post purification sample handling
16 Sep 2015
Genevac has developed a suite of proprietary technological solutions to facilitate post purification sample handling, including reformatting.
Read more
Horizon Discovery Group enters bioproduction cell line licensing agreement with LakePharma
16 Sep 2015
The terms of the license cover commercial use of a genetically-engineered Chinese Hamster Ovary (CHO) cell line, developed by Horizon and adapted to manufacturing conditions by LakePharma.
Read moreLogistics experts call for industry shake-up at FlyPharma Conference
16 Sep 2015
The conference highlighted common pharma logistics issues and stimulated an inclusive dialogue between key stakeholders in the supply chain.
Read more
AstraZeneca purchases US biologics manufacturing facility to support growing pipeline
16 Sep 2015
The LakeCentre facility, located in Boulder, Colorado will increase manufacturing and production capacity to support the company’s extensive portfolio of biologics medicines.
Read more
FDA establishes public docket to receive comments on enhancing the utility and usability of the inactive ingredient database
16 Sep 2015
FDA has announced the establishment of a public docket to receive comments from interested parties on enhancing the utility and usability of the Inactive Ingredient Database (IID) (also known as the Inactive Ingredient Guide). These comments will help ...
Read more
Bavarian Nordic receives contract valued at USD 9 million from Janssen as part of advanced development of prime-boost Ebola vaccine regimen
16 Sep 2015
The 5-year base subcontract covers studies to improve the manufacturing process and establish long-term storage of MVA-BN Filo bulk vaccine. The contract also includes options for an additional USD 24 million to implement process development activities...
Read more